February 2020

February 28, 2020

February 28, 2020

Categories

From the Co-Chairs

From the Co-Chairs, February 2020

January meeting with NCI leaders and the Cooperative Group Chairs; Congress increases NCI and overall NIH budget for FY 2020; EA opens two new trials, one for pancreatic cyst monitoring (EA2185) and the other to evaluate nivolumab in head and neck cancer (EA3161); plans are underway for the next Comis Symposium

February 28, 2020

Categories

Active Clinical Trials

Now Enrolling: EA2185 to Compare the Clinical Impact of Pancreatic Cyst Surveillance Programs

This trial is comparing two common surveillance methods in people with at least one non-cancerous cyst in the pancreas, to measure which one leads to better outcomes. The study may also uncover findings that could predict the behavior of these cysts.

February 28, 2020

Categories

Special Topics

Social Media and Clinical Trials

Mike Thompson writes that educating and engaging the public--both via social media and in person--is necessary to sustain a national clinical trials infrastructure and continue advancing cancer research

February 28, 2020

February 28, 2020

Categories

News in Brief, February 2020

February 28, 2020

Categories

Active Clinical Trials

Trial Spotlight: Nabil Saba on Study EA3161 for HPV Positive Head and Neck Cancer

This trial is evaluating maintenance nivolumab versus observation following intensity-modulated radiation therapy and cisplatin